<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGen</journal-id><journal-title-group><journal-title>Open Journal of Genetics</journal-title></journal-title-group><issn pub-type="epub">2162-4453</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgen.2018.83006</article-id><article-id pub-id-type="publisher-id">OJGen-87302</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Distribution of Genetic Polymorphism in the CCR5 among Caucasians, Asians and Africans: A Systematic Review and Meta-Analysis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Beatrice</surname><given-names>A. Ongadi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>George</surname><given-names>Obiero</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Raphael</surname><given-names>W. Lihana</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>John</surname><given-names>N. Kiiru</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Centre for Microbiology Research, Nairobi, Kenya</addr-line></aff><aff id="aff2"><addr-line>Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya</addr-line></aff><aff id="aff1"><addr-line>Centre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya</addr-line></aff><pub-date pub-type="epub"><day>13</day><month>07</month><year>2018</year></pub-date><volume>08</volume><issue>03</issue><fpage>54</fpage><lpage>66</lpage><history><date date-type="received"><day>18,</day>	<month>July</month>	<year>2018</year></date><date date-type="rev-recd"><day>11,</day>	<month>September</month>	<year>2018</year>	</date><date date-type="accepted"><day>14,</day>	<month>September</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background: </b>
  Cysteine-Cysteine Chemokine Receptor 5 (CCR5)
  ,
   also referred to as CD195
  ,
   is a component of the mammalian cell membrane and is receptor for chemokines that are activated during cell damage and inflammations. This receptor is coded by a gene located in the human chromosome 3. A Mutation on this CCR5 through deletion of 32 base pairs results into a non-destructive gene CCR5Δ32. It enables protection against HIV infection to its homozygous carriers
   
  and slows progression of the disease to heterozygous carriers. <b>Objective</b>: To systematically review and establish global distribution of CCR5Δ32 allele in HIV-1 infected individuals over the history of the epidemic and compare regions inhabited by Caucasians, Asians and Africans. <b>Methodology: </b>This meta-analysis comprised of published papers with over 10,000 individuals from whom CCR5-Delta
   
  32 allele was successfully genotyped and recorded. The study review period was from 1984 to 2017. The search targeted online sources such as Hinari specifically PubMed Central, Google scholar, Science Direct, Research4Life, National Center for Biotechnology Information (NCBI), OVID databases, AIDS Journal and Google. The searches were not limited to a particular publication language or study design but excluded letters of correspondence and conference presentations. Search strategy using key words from a combination of Medical Subject Heading (MeSH) and free text including terms related to CCR5, CCR5Δ32 and HIV were performed in Medical Literature Analysis and Retrieval System Online (MEDLINE) through Ovid
   
  Open
   
  Access. Additional studies were identified by perusing the reference list of relevant and included articles. The review considered studies conducted among general population, both HIV positive and HIV negative individuals, exposed seronegatives (ESN), exposed seropositives (ESP) and highly exposed seronegatives (HESN) and resultant data pooled using a fixed effect model. <b>Results: </b>A total of 40 studies comprising 10,871 participants were reviewed. These were from three main regions
  :
   Europe, Africa and Asia. Of the studies accessed and reviewed, Caucasians were 22.5%, Africans were 12.5%, Europeans were 27% and others (not specified) were 37.5%. The distribution of CCR5Δ32 allele among different populations in comparison to its heterozygosity displayed significant association with a pooled Odds Ratio (OR) of 0.08 (95%
   
  CI, 0.03
   - 
  0.18, P &lt; 0.00001), test of subgroup differences at I<sup>2</sup>
   
  =
   
  0% and a P value of 0.50.
   
  Among the Caucasians alone the OR was at 0.04 (95% CI, 0.01
   
  -
   
  0.19, I<sup>2</sup>
   
  = 96%) and a significant P value of &lt; 0.00001 displaying a high presence of CCR5Δ32 homozygosity as compared to Europeans with OR of 0.09 (95% CI, 0.04 - 0.19, I<sup>2</sup> = 21%, P = 0.25) and Africans with OR 0.25 (95% CI, 0.03 - 2.29, I<sup>2</sup> = 0%, P = 0.81); an indication that race can be a factor that determines CCR5Δ32 homozygosity or heterozygosity and it highly favors the Caucasians. Out of 136 homozygous carrie
  r
  s found in the review Europeans had 6%, Caucasian 93%, Africans 0% and others combined 0.7%. <b>Conclusion: </b>The distribution of CCR5Δ32, an allele that is associated with lower acquisition of HIV/AIDS is at 93% among the Caucasians. The remaining 7% is shared amongst the rest of the populations, hence high susceptibility to the disease. Minimal availability of recorded data experienced in this study is a clear indication that there exist major gaps in studies that could further associate CCR5Δ32 allele frequency and HIV infection in different populations. The review recommends a mixture of population genetics and epidemiological studies in trying to understand the increasing rates of HIV prevalence among selected groups.
 
</p></abstract><kwd-group><kwd>CCR5</kwd><kwd> CCR5Δ32</kwd><kwd> HIV</kwd><kwd> Genetic Polymorphism</kwd><kwd> Allele Frequency</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Mammalian cell membranes have cysteine-cysteine chemokine receptor 5 (CCR5) as a component. They are also referred to as CD195 and are popularly known for allowing in chemokines that signal cellular response during inflammation and after cellular damages [<xref ref-type="bibr" rid="scirp.87302-ref1">1</xref>] . The receptor (CCR5) is coded by a gene located in the human chromosome 3. Several known mutations of CCR5 result into damage of the expressed receptor either by deletion, insertion and or omission. The CCR5-Delta 32 (CCR5Δ32) is a damage resulting from a deletion of 32 base pairs of the CCR5 gene but the mutation is non-deleterious. This is unlike other genes that cause serious and harmful damages such as sickle cell anemia, cystic fibrosis, diabetes when knocked out. CCR5Δ32 mutation is suspected to confer various advantages to the host in relationship to HIV acquisition [<xref ref-type="bibr" rid="scirp.87302-ref2">2</xref>] . Previous studies have shown that individuals having homozygosity in CCR5Δ32 are hindered from HIV acquisitions while their heterozygous counterparts are slow progressers of the disease [<xref ref-type="bibr" rid="scirp.87302-ref3">3</xref>] .</p><p>In human, the distribution of CCR5Δ32 has a high geographical variation indicating adaptive traits and the co-evolution of HIV and the human genome [<xref ref-type="bibr" rid="scirp.87302-ref4">4</xref>] . This mutation results into a shortened protein that cannot be expressed on the surface hence giving a perceived resistance to HIV-1 infection, which in turn hinders faster progression to AIDS among infected persons [<xref ref-type="bibr" rid="scirp.87302-ref5">5</xref>] .</p><p>Population genetic surveys earlier estimated the existence of CCR5Δ32 allele among the Europeans at 10% while it was found missing among the black populace except African Americans who descended from admixture with Europeans [<xref ref-type="bibr" rid="scirp.87302-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.87302-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.87302-ref6">6</xref>] . The estimates were reached upon studying equally minimal samples of 747 non-European individuals against 4000 European or Caucasian [<xref ref-type="bibr" rid="scirp.87302-ref6">6</xref>] .</p><p>A meta-analysis on the accrued data on the distribution of CCR5Δ32 allele covering the critical HIV study period would help in generating statistics for advising on the best method to counter the spread of HIV across different populations. It would further assist in formulating a much better way of channeling prevention and treatment strategies taking into consideration current frequent travels across the globe and possible cross infections and gene flow among travelers.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Search Criteria and Study Selection</title><p>We searched available online sources such as Hinari specifically PubMed Central, English database of Google scholar, Science Direct, Research4Life, National Center for Biotechnology Information (NCBI), OVID databases, AIDS Journal and Google. The period of search was tailored to range from 1984 to 2017, however other relevant papers that were published before 1984 and after 2017 were enlisted to boost on literature review. Suitable published papers were identified and assembled using Mendeley desktop application. Search strategy using key words from a combination of Medical Subject Heading (MeSH) and free text including terms related to CCR5, CCR5Δ32 and HIV were performed in Medical Literature Analysis and Retrieval System Online (MEDLINE) through Ovid Open Access. Studies conducted among the following populations were accepted for review; general population, both HIV positive and HIV negative individuals, exposed seronegatives (ESN), exposed seropositives (ESP) and highly exposed seronegatives (HESN). To reduce reporting bias only studies with participants successfully genotyped for CCR5Δ32 and results accurately recorded were included. The PRISMA 2009 flow diagram [<xref ref-type="bibr" rid="scirp.87302-ref7">7</xref>] was used to summarize details on data identification, screening and eligibility. A predetermined and comprehensive inclusion and exclusion criteria was arrived at to facilitate objective screening of different articles. Only published and original articles on the distribution of CCR5Δ32 allele in HIV-1 infected individuals from various countries were included for the review. Letters of correspondence, papers with missing relevant data and conference presentations were excluded in this review.</p></sec><sec id="s2_2"><title>2.2. Data Abstraction and Statistical Analysis</title><p>For accurate data abstraction, an excel sheet was used.</p><p>Odds Ratios (OR) were used to assess the distribution of CCR5Δ32 allele among different populations grouped as Caucasians, African, Europeans and Others. The ratio was also used to evaluate the association of CCR5Δ32 heterozygotes and homozygotes with vulnerability to HIV infection. The Chi-square (X<sup>2</sup>) and I<sup>2</sup> were used to test for the presence of, quantify and determine heterogeneity across studies [<xref ref-type="bibr" rid="scirp.87302-ref8">8</xref>] . P-Value of less than 0.10 was used to indicate statistical significance and publication bias accessed by a simple graphical test by Egger and Begg [<xref ref-type="bibr" rid="scirp.87302-ref9">9</xref>] .</p></sec></sec><sec id="s3"><title>3. Results</title><p>A total of 544 relevant and non-duplicate articles were retrieved. From this, 144 articles were subjected to further analysis. The final 37 articles with 17,353 participants were accepted for inclusion in the meta-analysis (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The search was conducted in two main phases; first a group of three reviewers independently cataloguing articles as per the agreed criteria. The result of the initial phase was cross checked by an independent reviewer to ensure an agreement accuracy of 90% and above. The second phase involved full text review and confirmation for inclusion suitability. Uncertainties and conflict of opinions were discussed and resolved in consensus by the reviewers.</p><p>Major and complete studies available for review were realized among the Caucasian population totaling to eighteen (18). The earliest study to be reviewed was conducted by Martison and group in 1997. It was done after successful characterization of the mutant allele and on realization that isolated cases of HIV positive homozygotes were still emerging. This study involved 3324 unrelated individuals from a globally distributed population and remains the largest so far in this review; studies that followed are relatively smaller and not so globally constituted. Nine studies with complete genotyped individuals were available for analysis from Asia while six studies covered Africa population and four studies under the ungrouped (others) category (<xref ref-type="table" rid="table1">Table 1</xref>). The largest share of the population reviewed were the Caucasians at 50% with a total of 52 CCR5Δ32 Homozygotes (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>From the forest plot, there is a clear indication that most studies reviewed and meta-analyzed were from Caucasians population (<xref ref-type="fig" rid="fig3">Figure 3</xref>). These studies carried a lot of weight and significance as evidenced by the size and visibility of the small squares in the plot. With heterogeneity at 62%, it is observable that being a Caucasian is a factor for CCR5Δ32 homozygosity hence it can be assumed that this is a protected population in terms of the allele. With heterogeneity at 31% being an Asian is not a sure factor for CCR5Δ32 homozygosity hence no protection from HIV infection; few cases presenting the allele here could be as a result of gene flow or descendants of admixture with Caucasians. Scanty data was seen among the African population, out of six studies analyzed only three had events complete for estimation, others were at zero for both homozygosity and heterozygosity. Studies carried out among African population had heterogeneity of 0% hence being an African is clearly not a factor for CCR5Δ32 homozygosity. The overall outcome for all the populations meta-analyzed indicates that race can be a factor that determines CCR5Δ32 homozygosity or heterozygosity and it highly favors the Caucasians.</p><p>A correlation and a strong indication that CCR5Δ32 homozygosity can be a shield to HIV virulence is realized from the results of the analysis for both HIV Positive and HIV negative individuals genotyped (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><p>Table1. Characteristics of all studies selected and grouped for review and meta-analysis (GP―General Population, SN―Seronegatives, SP―Seropositives, ESN―Exposed Seronegatives, HESN―Highly Exposed Seronegatives).</p></sec><sec id="s4"><title>4. Discussions</title><p>This review correlated data from studies on the distribution of CCR5Δ32 which is a natural selection allele acting in humans against HIV/AIDS as demonstrated by previous studies [<xref ref-type="bibr" rid="scirp.87302-ref6">6</xref>] . The result of this meta-analysis involving 37 articles with 17,253 participants from diverse backgrounds sheds great lights on the distribution of this allele globally as well its association with HIV-1 epidemiology. The study undoubtedly demonstrates that there is a wide knowledge gap on CCR5Δ32 especially in African where HIV burden is highest but further confirms that CCR5Δ32 heterozygosity does not protect individuals against HIV-1 infection but rather slows progression of the disease [<xref ref-type="bibr" rid="scirp.87302-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.87302-ref42">42</xref>] .</p><p>High concentration of studies on CCR5Δ32 is seen among the Caucasians. Globally 50% of the articles available for review covered this population while only three complete articles from African population were found representing less that 10%. Details from the study equally indicate that there is a likelihood of being homozygous of the allele when a Caucasian than any other race since most CCR5Δ32 homozygotes were Caucasians. However the few homozygotes seen among the Asian group could have been as a result of gene flow [<xref ref-type="bibr" rid="scirp.87302-ref6">6</xref>] . Notably, among African population no one was positive for the allele while in the remaining un-grouped population only one individual was present in Nigeria as recorded by Martison and group in 1997 [<xref ref-type="bibr" rid="scirp.87302-ref6">6</xref>] .</p><p>There is a possibility that the results in our study may be regionally and racially biased based on the data available online. Language bias, especially on manuscripts published in other languages other than English may also be another factor that could have affected our analysis.</p></sec><sec id="s5"><title>5. Conclusion</title><p>This meta-analysis is in line with previous various studies and concludes that CCR5Δ32 is highly concentered among the Caucasians as compared to other populations. From the systematic review conducted; 91% of the total number of individuals who were found to be CCR5 homozygous are Caucasians and 50% of articles available for review were also from that same region. Likewise, results presented here indicate that Caucasians as compared to other populations are less susceptible to HIV virus infection due to the expression rates of CCR5Δ32 while the rest of the populations experience a much higher prevalence of the disease. However, scanty data experienced is Africa is a clear indication that minimal work has been done in trying to associate the allele and HIV infection in different populations. This study recommends further studies on relevant contextual factors including but not limited to social, economic and nutritional factors given that a lot of cross-border travels and inter-race marriages has occurred over the years. A mixture of population genetics and epidemiological studies can also be explored.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Ongadi, B.A., Obiero, G., Lihana, R.W. and Kiiru, J.N. (2018) Distribution of Genetic Polymorphism in the CCR5 among Caucasians, Asians and Africans: A Systematic Review and Meta-Analysis. Open Journal of Genetics, 8, 54-66. https://doi.org/10.4236/ojgen.2018.83006</p></sec></body><back><ref-list><title>References</title><ref id="scirp.87302-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Rottman, J.B., Ganley, K.P., Williams, K., Wu, L., Mackay, C.R. and Ringler, D.J. (1997) Cellular Localization of the Chemokine Receptor CCR5: Correlation to Cellular Targets of HIV-1 Infection. American Journal of Pathology, 151, 1341-1351.</mixed-citation></ref><ref id="scirp.87302-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawamura</surname><given-names> et al. </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>R5 HIV Productively Infects Langerhans Cells, and Infection Levels Are Regulated by Compound CCR5 Polymorphisms</article-title><source> Proceedings of the National Academy of Sciences of the USA</source><volume> 100</volume>,<fpage> 8401</fpage>-<lpage>8406</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.87302-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., et al. (1996) Homozygous Defect in HIV-1 Corrector Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection. Cell, 86, 367-377. https://doi.org/10.1016/S0092-8674(00)80110-5</mixed-citation></ref><ref id="scirp.87302-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.-M., et al. (1996) Resistance to HIV-1 Infection in Caucasian Individuals Bearing Mutantalleles of the CCR-5 Chemokine Receptor Gene. Nature, 382, 722-725. https://doi.org/10.1038/382722a0</mixed-citation></ref><ref id="scirp.87302-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Gupta, A. and Padh, H. (2012) The Global Distribution of CCR5 Delta 32 Polymorphism: Role in HIV-1 Protection. BMC Infectious Diseases, 12, O16. https://doi.org/10.1186/1471-2334-12-S1-O16</mixed-citation></ref><ref id="scirp.87302-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Martinson, J.J., Chapman, N.H., Rees, D.C. and Clegg, J.B. (1997) Global Distribution of the CCR5 Gene 32-Basepair Deletion. Nature Genetics, 16, 100-103.</mixed-citation></ref><ref id="scirp.87302-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Moher, D., Liberati, A., Tetzlaff, J. and Altman, D.G. (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Medicine [Internet], 6, e1000097. https://doi.org/10.1371/journal.pmed.1000097</mixed-citation></ref><ref id="scirp.87302-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Cochran, W.G. (1954) The Combination of Estimates from Different Experiments. Biometrics, 10, 101-129. https://doi.org/10.2307/3001666</mixed-citation></ref><ref id="scirp.87302-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Egger, M., Smith, G.D., Schneider, M. and Minder, C. (1997) Bias in Meta-Analysis Detected by a Simple, Graphical Test. BMJ, 315, 29-34.</mixed-citation></ref><ref id="scirp.87302-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Oh, D.-Y., Jessen, H., Kücherer, C., Neumann, K., Oh, N., Poggensee, G., et al. (2008) CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual. PLoS ONE, 3, e2747. https://doi.org/10.1371/journal.pone.0002747</mixed-citation></ref><ref id="scirp.87302-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Al-Mahruqi, S.H., Zadjali, F., Beja-Pereira, A., Koh, C.Y., Balkhair, A. and Al-Jabri, A.A. (2014) Genetic Diversity and Prevalence of CCR2-CCR5 Gene Polymorphisms in the Omani Population. Genetics and Molecular Biology, 37, 7-14.</mixed-citation></ref><ref id="scirp.87302-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Trecarichi, E.M., Tumbarello, M., de Gaetano Donati, K., Tamburrini, E., Cauda, R., Brahe, C. and Tiziano, F.D. (2006) Partial Protective Effect of CCR5-Delta 32 Heterozygosity in a Cohort of Heterosexual Italian HIV-1 Exposed Uninfected Individuals. AIDS Research and Therapy, 3, 22.</mixed-citation></ref><ref id="scirp.87302-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Smoljanovic, M., Ristic, S. and Hayward, C. (2006) Historic Exposure to Plague and Present-day Frequency of CCR5del32 in Two Isolated Island Communities of Dalmatia, Croatia. Croatian Medical Journal, 47, 579-584.</mixed-citation></ref><ref id="scirp.87302-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Lopes, M.P., Santos, M.N.N., Faber, E.W., Bezerra, M.A.C., Hatzlhofer, B.L.D., Albuquerque, D.M., et al. (2014) The CCR5Δ32 Polymorphism in Brazilian Patients with Sickle Cell Disease. Disease Markers, 2014, Article ID: 678246.</mixed-citation></ref><ref id="scirp.87302-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Chavhan, A.B., Pawar, S.S., Jadhao, R.G. and Patil, K.G. (2013) Distribution of CC-Chemokine Receptor-5-&amp;#916;32 Allele among the Tribal and Caste Population of Vidarbha Region of Maharashtra State. Indian Journal of Human Genetics, 19, 65-70. https://doi.org/10.4103/0971-6866.112894</mixed-citation></ref><ref id="scirp.87302-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Rahimi, H., Farajollahi, M.M. and Hosseini, A. (2014) Distribution of the Mutated Delta 32 Allele of CCR5 Co-Receptor Gene in Iranian Population. Medical Journal of the Islamic Republic of Iran, 28, 140.</mixed-citation></ref><ref id="scirp.87302-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Biloglav, Z., et al. (2009) Historic, Demographic, and Genetic Evidence for Increased Population Frequencies of CCR5 Δ32 Mutation in Croatian Island Isolates after Lethal 15th Century Epidemics. Croatian Medical Journal, 50, 34-42. https://doi.org/10.3325/cmj.2009.50.34</mixed-citation></ref><ref id="scirp.87302-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Kostrikis, L.G., et al. (1999) A Polymorphism in the Regulatory Region of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants. Journal of Virology, 73, 10264-10271.</mixed-citation></ref><ref id="scirp.87302-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Nkenfou, C.N., Mekue, L.C.M., Nana, C.T. and Kuiate, J.R. (2013) Distribution of CCR5-Delta32, CCR5 Promoter 59029 A/G, CCR2-64I and SDF1-3’A Genetic Polymorphisms in HIV-1 Infected and Uninfected Patients in the West Region of Cameroon. BMC Research Notes, 6, 288. https://doi.org/10.1186/1756-0500-6-288</mixed-citation></ref><ref id="scirp.87302-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Bharti, D., et al. (2015) Low Prevalence of CCR5-Δ32, CCR2-64I and SDF1-3’A Alleles in the Baiga and Gond Tribes of Central India. SpringerPlus, 4, 451. https://doi.org/10.1186/s40064-015-1238-6</mixed-citation></ref><ref id="scirp.87302-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Heydarifard, Z., Tabarraei, A. and Moradi, A. (2017) Polymorphisms in CCR5-Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran. Disease Markers, 2017, Article ID: 4190107.</mixed-citation></ref><ref id="scirp.87302-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Roy, P. and Chakrabarti, S. (2015) Mutation in AIDS Restriction Gene Affecting HIV Infection and Disease Progression in a High Risk Group from Northeastern India. Medical Journal Armed Forces India, 72, 111-115.</mixed-citation></ref><ref id="scirp.87302-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Zapata, W., et al. (2013) Influence of CCR5 and CCR2 Genetic Variants in the Resistance/Susceptibility to HIV in Serodiscordant Couples from Colombia. AIDS Research and Human Retroviruses, 29, 1594-1603. https://doi.org/10.1089/aid.2012.0299</mixed-citation></ref><ref id="scirp.87302-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Mehlotra, R.K., et al. (2015) CCR2, CCR5, and CXCL12 Variation and HIV/AIDS in Papua New Guinea. Infection, Genetics and Evolution, 36, 165-173.</mixed-citation></ref><ref id="scirp.87302-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">de Lima Guerra, A., et al. (2016) Frequency of CCR5 Genotypes in HIV-Infected Patients in Roraima, Brazil. Brazilian Journal of Infectious Diseases, 20, 314-315. https://doi.org/10.1016/j.bjid.2016.01.001</mixed-citation></ref><ref id="scirp.87302-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Angelis, D.S., et al. (2007) CCR5 Genotypes and Progression to HIV Disease in Perinatally Infected Children. Brazilian Journal of Infectious Diseases, 11, 196-198. https://doi.org/10.1590/S1413-86702007000200004</mixed-citation></ref><ref id="scirp.87302-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Vargas, A.E., Marrero, A.R., Salzano, F.M., Bortolini, M.C. and Chies, J.A.B. (2006) Frequency of CCR5 Delta32 in Brazilian Populations. Brazilian Journal of Medical and Biological Research, 39, 321-325. https://doi.org/10.1590/S0100-879X2006000300002</mixed-citation></ref><ref id="scirp.87302-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Munerato, P., et al. (2003) Frequency of Polymorphisms of Genes Coding for HIV-1 Co-Receptors CCR5 and CCR2 in a Brazilian Population. Brazilian Journal of Infectious Diseases, 7, 236-240.</mixed-citation></ref><ref id="scirp.87302-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Díaz, F.J., et al. (2000) Frequency of CCR5 Delta-32 Mutation in Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Exposed Seronegative Individuals and in General Population of Medellin, Colombia. Memórias do Instituto Oswaldo Cruz, 95, 237-242. https://doi.org/10.1590/S0074-02762000000200018</mixed-citation></ref><ref id="scirp.87302-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Pereira, R.W., et al. (2000) Frequency of the CCR Delta32 Allele in Brazilians: A Study in Colorectal Cancer and in HTLV-I Infection. Genetics and Molecular Biology, 23, 523-526. https://doi.org/10.1590/S1415-47572000000300003</mixed-citation></ref><ref id="scirp.87302-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Rugeles, M.T., Velilla, P.A. and Montoya, C.J. (2011) Mechanisms of Human Natural Resistance to HIV: A Summary of Ten Years of Research in the Colombian Population. Biomédica, 31, 269-280.</mixed-citation></ref><ref id="scirp.87302-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Valadez-González (2011) Implicación del alelo CCR5-Δ32 en la progresión clínica de pacientes VIH-1 + en Yucatán, Méxic.</mixed-citation></ref><ref id="scirp.87302-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Salem, A.H., et al. (2009) Epidemiology Distribution of Four HIV Type 1-Resistance Polymorphisms (CCR5-Δ32, CCR5-m303, CCR2-64I, and SDF1-3’A) in the Bahraini Population. AIDS Research and Human Retroviruses, 25, 973-977.</mixed-citation></ref><ref id="scirp.87302-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Yudin, N.S., et al. (1998) Distribution of CCR5-Delta32 Gene Deletion across the Russian Part of Eurasia. Human Genetics, 102, 695-698.</mixed-citation></ref><ref id="scirp.87302-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Grigory (2004) Genetic Testing.</mixed-citation></ref><ref id="scirp.87302-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">John, G.C., et al. (2001) CCR5 Promoter Polymorphisms in a Kenyan Perinatal Human Immunodeficiency Virus Type 1 Cohort: Association with Increased 2-Year Maternal Mortality. The Journal of Infectious Diseases, 184, 89-92. https://doi.org/10.1086/321006</mixed-citation></ref><ref id="scirp.87302-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Sidoti, A., et al. (2005) Distribution of the Mutated Δ32 Allele of the CCR5 Gene in a Sicilian Population. International Journal of Immunogenetics, 32, 193-198. https://doi.org/10.1111/j.1744-313X.2005.00507.x</mixed-citation></ref><ref id="scirp.87302-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Mangano, A., Theiler, G., Sala, L., Capucchio, M., Fainboim, L. and Sen, L. (2001) Distribution of CCR5-Δ32 and CCR2-64I Alleles in an Argentine Amerindian Population, Alleles in an Argentine Amerindian Population. Tissue Antigens, 58, 99-102.http://login.research4life.org/tacsgr1doi_org/10.1034/j.1399-0039.2001.580207.x</mixed-citation></ref><ref id="scirp.87302-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Torimiro, J.N., et al. (2004) Frequency of CCR5 Variants among Rural Populations with Low HIV-1 Prevalence in Cameroon. AIDS, 21, 527-528.</mixed-citation></ref><ref id="scirp.87302-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Al-Jaberi, S.A., Ben-Salem, S., Messedi, M., Ayadi, F., Al-Gazali, L. and Ali, B.R. (2013) Determination of the CCR5 &amp;#916;32 Frequency in Emiratis and Tunisians and the Screening of the CCR5 Gene for Novel Alleles in Emiratis. Gene, 529, 113-118.</mixed-citation></ref><ref id="scirp.87302-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Kalev, I., Mikelsaar, A.-V., Beckman, L., Tasa, G. and Parlist, P. (2000) High Frequency of the HIV-1 Protective CCR5 Δ32 Deletion in Native Estonians. European Journal of Epidemiology, 16, 1107-1109. https://doi.org/10.1023/A:1010829816334</mixed-citation></ref><ref id="scirp.87302-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Contopoulos-Ioannidis, D.G., et al. (2003) Effect of CCR5-Delta32 Heterozygosity on the Risk of Perinatal HIV-1 Infection: A Meta-Analysis. Journal of Acquired Immune Deficiency Syndromes, 32, 70-76. https://doi.org/10.1097/00126334-200301010-00010</mixed-citation></ref></ref-list></back></article>